Trials / Completed
CompletedNCT02409212
Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer
Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer: the PANTERA Trial (Prostate cAncer Novel ThERApy)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Study design: The study is a two arm randomised controlled trial (randomisation ratio 1:1) comparing an aerobic exercise training intervention to usual care plus exercise advice. The primary outcome is the feasibility of the intervention as novel primary therapy in men with localised prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Aerobic exercise training | Aerobic exercise training will be undertaken for 12 months, combining supervised and independent exercise sessions. Behaviour change counselling will take place bi-monthly, either via face to face sessions during exercise or via telephone by study clinical exercise specialist according to participant preference. |
| BEHAVIORAL | Placebo surveillance and written exercise guidelines | Optimal active surveillance according to NICE guidelines and written exercise guidelines from Macmillan cancer |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2015-04-06
- Last updated
- 2019-01-30
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02409212. Inclusion in this directory is not an endorsement.